Citations (7)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Shilan Mozaffari, Shekoufeh Nikfar & Mohammad Abdollahi. (2014) The safety of novel drugs used to treat irritable bowel syndrome. Expert Opinion on Drug Safety 13:5, pages 625-638.
Read now
Read now
Articles from other publishers (6)
Gururaja Perumal Pazhani, Murugan Veerapandian, Rajkumar Malayandi & Thandavarayan Ramamurthy. 2022. Human Microbiome. Human Microbiome
193
213
.
Tomoyuki Ishigo, Tatsuto Shimotsubo, Ryo Takada, Keita Nakano, Satoshi Fujii, Manabu Kitagawa, Tomoko Kimyo, Hiromasa Nakata & Masahide Fukudo. (2021) Efficacy and Safety of Linaclotide in Elderly Patients高齢者に対するリナクロチドの有効性と安全性の検討. YAKUGAKU ZASSHI 141:2, pages 255-262.
Crossref
Crossref
Takatsugu Yamamoto, Shun Osumi, Daisuke Yanagisawa, Hiroshi Yamato, Hitoshi Aoyagi, Akari Isono, Koichiro Abe & Hiroto Kita. (2017) Possible Effect of Concomitant Prokinetics and Herbal Medicines against Nausea in Patients Taking Lubiprostone. BioMed Research International 2017, pages 1-3.
Crossref
Crossref
Hani Essa & Shaheen Hamdy. (2016) Evaluating the Scope of Gastrointestinal Symptoms of Parkinson's Disease: A Review of the Evidence. Neuroenterology 4, pages 1-12.
Crossref
Crossref
Tatsuya Abe, Yoshikazu Hachiro, Yoshiaki Ebisawa, Houhei Hishiyama & Masao Kunimoto. (2016) Efficacy and Safety of Oral Lubiprostone in the Management of Chronic Constipation. Nippon Daicho Komonbyo Gakkai Zasshi 69:1, pages 6-10.
Crossref
Crossref
Yuri Iwata, Yosuke Kunishi & Koichiro Yoshie. (2015) Obstructive Uropathy Caused by Chronic Constipation. Internal Medicine 54:9, pages 1043-1047.
Crossref
Crossref